Growth hormone-IGF-I axis and growth velocity in Chinese children with type 1 diabetes mellitus

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue 11, 2006, Pages 1313-1318

  Li, Guimei ^a   Mick, Gail ^b   Wang, Xudong ^b   Xue, Jiang ^a   McCormick, Kenneth ^b  

^a SHANDONG UNIVERSITY   (China)

^b University of Alabama at Birmingham   (United States)

Author keywords

Children; Growth retardation; Insulin like growth factor I; Mean HbA1c; Type 1 diabetes mellitus

Indexed keywords

GROWTH HORMONE; HEMOGLOBIN A1C; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; CHILD; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH RATE; GROWTH RETARDATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LINEAR REGRESSION ANALYSIS; MALE; PREPUBERTY; PROTEIN BLOOD LEVEL;

EID: 33845720382     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2006.19.11.1313     Document Type: Article

References (32)

1. Lehman RM. Poorly controlled diabetes? Adolesc Med 1996; 7: 405-408.
2. Tamborlane WV, Hintz RL, Bergman M, Genel M, Felig P, Sherwin RS. Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels. N Engl J Med 1981; 305: 303-307.
3. Salardi S, Cacciari E, Ballardini D, Righetti F, Capelli M, Cicognani A, Zucchini S, Natali G, Tassinari D. Relationships between growth factors (somatomedin-C and growth hormone) and body development, metabolic control, and retinal changes in children and adolescents with IDDM. Diabetes 1986; 35: 832-836.
4. Wacharasindhu S, Srivuthana S, Aroonparkmongkol S. Insulin-like growth factors and their binding proteins in children with IDDM. J Med Assoc Thai 2002; 85: 41-52,
5. Amiel SA, Sherwin RS, Hintz RL, Gertner JM, Press CM, Tamborlane WV. Effect of diabetes and its control on insulin-like growth factors in the young subject with type I diabetes. Diabetes 1984; 33: 1175-1179.
6. Dunger DB, Regan FM, Acerini CL. Childhood and adolescent diabetes. Endocr Dev 2005; 9: 107-120.
7. 1c levels, sex, and bone age. Diabetes Care 1998; 21: 831-835.
8. Hedman CA, Frystyk J, Lindstrom T, Chen JW, Flyvbjerg A, Orskov H, Arnqvist HJ. Residual beta-cell function more than glycemic control determines abnormalities of the insulin-like growth factor system in type 1 diabetes. J Clin Endocrinol Metab 2004; 89: 6305-6309.
9. Pitukcheewanont P, Alemzadeh R, Jacobs WR, Jones BH, Eberle AJ. Does glycemic control affect growth velocity in children with insulin-dependent diabetes mellitus? Acta Diabetol 1995; 32: 148-152.
10. Dills DG, Allen C, Palta M, Zaccaro DJ, Klein R, D'Alessio D. Insulin-like growth factor-I is related to glycemic control in children and adolescents with newly diagnosed insulin-dependent diabetes. J Clin Endocrinol Metab 1995; 80: 2139-2143.
11. Rogers DG, Sherman LD, Gabbay KH. Effect of puberty on insulin-like growth factor I and HbA1 in type I diabetes. Diabetes Care 1991; 14: 1031-1035.
12. Taylor AM, Dunger DB, Grant DB, Preece MA. Somatomedin-C/IGF-I measured by radioimmunoassay and somatomedin bioactivity in adolescents with insulin dependent diabetes compared with puberty matched controls. Diabetes Res 1988; 9: 177-181.
13. Merimee TJ, Gardner DF, Zapf J, Froesch ER. Effect of glycemic control on serum insulin-like growth factors in diabetes mellitus. Diabetes 1984; 33: 790-793.
14. Massa G, Dooms L, Bouillon R, Vanderschueren-Lodeweyckx M. Serum levels of growth hormone-binding protein and insulin-like growth factor I in children and adolescents with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 239-243.
15. Bereket A, Lang CH, Blethen SL, Ng LC, Wilson TA. Insulin treatment normalizes reduced free insulin-like growth factor-I concentrations in diabetic children. Clin Endocrinol (Oxf) 1996; 45: 321-326.
16. Zachrisson I, Brismar K, Hall K, Wallensteen M, Dahlqvist G. Determinants of growth in diabetic pubertal subjects. Diabetes Care 1997; 20: 1261-1265.
17. Chiarelli F, Giannini C, Mohn A. Growth, growth factors and diabetes. Eur J Endocrinol 2004; 151 (Suppl 3): U109-117.
18. Rudolf MC, Sherwin RS, Markowitz R, Bates SE, Genel M, Hochstadt J, Tamborlane WV. Effect of intensive insulin treatment on linear growth in the young diabetic patient. J Pediatr 1982; 101: 333-339.
19. Salardi S, Tonioli S, Tassoni P, Tellarini M, Mazzanti L, Cacciari E. Growth and growth factors in diabetes mellitus. Arch Dis Child 1987; 62: 57-62.
20. Wurzburger MI, Sonksen PH. Natural course of growth hormone hypersecretion in insulin-dependent diabetes mellitus. Med Hypotheses 1996; 46: 145-149.
21. Press M, Tamborlane WV, Sherwin RS. Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes. N Engl J Med 1984; 310: 810-815.
22. Lanes R, Recker B, Fort P, Lifshitz F. Impaired somatomedin generation test in children with insulin-dependent diabetes mellitus. Diabetes 1985; 34: 156-160.
23. Edge JA, Hourd P, Edwards R, Dunger DB. Urinary growth hormone during puberty in normal and diabetic children. Clin Endocrinol (Oxf) 1989; 30: 413-420.
24. Krassowski J, Felber JP, Rogala H, Jeske W, Zgliczynski S. Exaggerated growth hormone response to growth hormone-releasing hormone in type I diabetes mellitus. Acta Endocrinol (Copenh) 1988; 117: 225-229.
25. Mayfield J. Diagnosis and classification of diabetes mellitus: new criteria. Am Fam Physician 1998; 58: 1355-1362, 1369-1370.
26. Leung KC, Doyle N, Ballesteros M, Waters MJ, Ho KK. Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation. J Clin Endocrinol Metab 2000; 85: 4712-4720.
27. Brismar K, Fernqvist-Forbes E, Wahren J, Hall K. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab 1994; 79: 872-878.
28. Bereket A, Lang CH, Blethen SL, Fan J, Frost RA, Wilson TA. Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity. J Clin Endocrinol Metab 1995; 80: 2282-2288.
29. Bang P, Brismar K, Rosenfeld RG. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex. J Clin Endocrinol Metab 1994; 78: 1119-1127.
30. Huddle KR, Gill GV, Krige LP. Limited joint mobility in Black patients with type I diabetes mellitus. S Afr Med J 1983; 64: 579-581.
31. Tattersall RB, Pyke DA. Growth in diabetic children. Studies in identical twins. Lancet 1973; ii: 1105-1109.
32. Salerno M, Argenziano A, Di Maio S, Gasparini N, Formicola S, De Filippo G, Tenore A. Pubertal growth, sexual maturation, and final height in children with IDDM. Effects of age at onset and metabolic control. Diabetes Care 1997; 20: 721-724.